Page last updated: 2024-11-04

sumatriptan and MELAS

sumatriptan has been researched along with MELAS in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iizuka, T1
Sakai, F1
Endo, M1
Suzuki, N1

Other Studies

1 other study available for sumatriptan and MELAS

ArticleYear
Response to sumatriptan in headache of MELAS syndrome.
    Neurology, 2003, Aug-26, Volume: 61, Issue:4

    Topics: Adult; Drug Evaluation; Female; Headache; Humans; Hyperemia; MELAS Syndrome; Parietal Lobe; Phenotyp

2003